Michael Low - Search Results

Year	Number of Results
2005	2
2006	1
2007	2
2009	1
2012	1
2013	3
2014	2
2015	1
2016	4
2017	5
2018	5
2019	1
2020	5
2021	7
2022	6
2023	2
2024	3

1

Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised study.

Dimopoulos MA, Hungria VTM, Radinoff A, Delimpasi S, Mikala G, Masszi T, Li J, Capra M, Maiolino A, Pappa V, Chraniuk D, Osipov I, Leleu X, Low M, Matsumoto M, Sule N, Li M, McKeown A, He W, Bright S, Currie B, Perera S, Boyle J, Roy-Ghanta S, Opalinska J, Weisel K. Dimopoulos MA, et al. Among authors: low m. Lancet Haematol. 2023 Oct;10(10):e801-e812. doi: 10.1016/S2352-3026(23)00243-0. Lancet Haematol. 2023. PMID: 37793771 Clinical Trial.

2

Daily iron supplementation for improving anaemia, iron status and health in menstruating women.

Low MS, Speedy J, Styles CE, De-Regil LM, Pasricha SR. Low MS, et al. Cochrane Database Syst Rev. 2016 Apr 18;4(4):CD009747. doi: 10.1002/14651858.CD009747.pub2. Cochrane Database Syst Rev. 2016. PMID: 27087396 Free PMC article. Review.

3

Targeted Therapies for Multiple Myeloma.

Leow CC, Low MSY. Leow CC, et al. Among authors: low msy. J Pers Med. 2021 Apr 23;11(5):334. doi: 10.3390/jpm11050334. J Pers Med. 2021. PMID: 33922567 Free PMC article. Review.

4

Low mortality in vaccinated immunocompromised haematology patients infected with SARS-CoV-2.

Shaw B, Shortt J, Low M, Rogers B, Kaplan Z, Fedele P, Gregory G, Vilcassim S, Gilbertson M, Grigoriadis G, Opat S. Shaw B, et al. Among authors: low m. Intern Med J. 2022 Dec;52(12):2172-2175. doi: 10.1111/imj.15954. Epub 2022 Nov 27. Intern Med J. 2022. PMID: 36436197

5

Iron deficiency and new insights into therapy.

Low MS, Grigoriadis G. Low MS, et al. Med J Aust. 2017 Jul 17;207(2):81-87. doi: 10.5694/mja16.01304. Med J Aust. 2017. PMID: 28701129 Review.

6

Lyn, Lupus, and (B) Lymphocytes, a Lesson on the Critical Balance of Kinase Signaling in Immunity.

Brodie EJ, Infantino S, Low MSY, Tarlinton DM. Brodie EJ, et al. Among authors: low msy. Front Immunol. 2018 Mar 1;9:401. doi: 10.3389/fimmu.2018.00401. eCollection 2018. Front Immunol. 2018. PMID: 29545808 Free PMC article. Review.

7

Thrombocytopenia, splenomegaly, and periportal fibrosis in a migrant.

Phan T, Low MSY, Low K, Braude M. Phan T, et al. Among authors: low msy. Ann Hematol. 2022 Aug;101(8):1883-1884. doi: 10.1007/s00277-022-04838-3. Epub 2022 Apr 20. Ann Hematol. 2022. PMID: 35441857 No abstract available.

8

Concomitant diagnosis of chronic myeloid leukaemia and myeloma.

Looi W, Zargari A, Dun K, Grigoriadis G, Fedele P, Gregory GP, Low MSY. Looi W, et al. Among authors: low msy. Pathology. 2022 Jun;54(4):493-495. doi: 10.1016/j.pathol.2021.08.007. Epub 2021 Nov 11. Pathology. 2022. PMID: 34776244 No abstract available.

9

Targeting plasma cells: are we any closer to a panacea for diseases of antibody-secreting cells?

Low M, Infantino S, Grigoriadis G, Tarlinton D. Low M, et al. Immunol Rev. 2016 Mar;270(1):78-94. doi: 10.1111/imr.12388. Immunol Rev. 2016. PMID: 26864106 Review.

10

HIV Vaccines: One Step Closer.

Low MSY, Tarlinton D. Low MSY, et al. Trends Mol Med. 2017 Jan;23(1):1-3. doi: 10.1016/j.molmed.2016.10.006. Epub 2016 Nov 23. Trends Mol Med. 2017. PMID: 27889424

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

46 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year